健民龙牡品牌怎么样 申请店铺

我要投票 健民龙牡在中草药行业中的票数:394 更新时间:2025-07-27
健民龙牡是哪个国家的品牌?「健民龙牡」是 健民药业集团股份有限公司 旗下著名品牌。该品牌发源于湖北,由创始人刘勤强在1993期间创立,经过多年的不懈努力和高速发展,现已成为行业的标杆品牌。

外推网助力健民龙牡品牌出海!将品牌入驻外推网,定制健民龙牡品牌推广信息,可以显著提高健民龙牡产品曝光,简直是跨境电商爆单神器!目前仅需1000元/年哦~

健民龙牡怎么样

龙牡壮骨颗粒是武汉健民集团旗下一个有着近20年辉煌历史、创造了中国医药界长盛不衰奇迹的知

名品牌,整整抚育了中国两代儿童的健康成长。
龙牡壮骨颗粒的的主要药材(如茯苓、麦冬等)都直接选用武汉健民集团专门建设的GAP药材种植

基地的原料,药材天然地道。生产过程中的每个环节、每道工序都有严格的质控标准,做到了“不合

格的原料不进厂,不合格的半成品不转到下道工序,不合格的产品不出厂”。

龙牡壮骨颗粒问世18年,畅销了18年,累计60亿袋的产量。“龙牡”的面世和畅销,创造了令人惊叹

的市场业绩和品牌价值,也使得武汉健民——一个有着悠久历史、而却依然年轻的企业焕发出勃勃的

生机,从此享誉长城内外,大江南北。

“龙牡”,曾经独领儿童补钙产品市场的风骚。而如今,它却受到了来自其它同类竞品的强力竞

争和挑战,面临着市场份额被不断蚕食和瓜分的严峻局面。

抚育了中国整整二代人的茁壮成长。

1985年在武汉市儿童医院出生,填补了我国以中药为主体,防治小儿佝偻病的空白;

1990年被收载入湖北省药品标准;

1992年被列为国家唯一的补钙一级中药保护品种;

1993年被中国儿童保护中心推荐为最佳小儿补钙、促进钙质吸收药品;

1994年被全国佝偻病防治协作组列为首推中成药;

1995年被收载入卫生部药品标准;

1999年被列为国家基本药物;

2000年被中国药典2000版收载;

2002年被列为国家处方药与非处方药(OTC)双跨品种;

同年,被《中医儿科学》(新世纪全国高等中医院校规划教材)收载。

武汉健民为中国医药工业50强企业,集团股份有限公司是国家重点高新技术企业、全国中成药小儿用药生产基地、全国重点中药企业。集团的前身是中国最古老的四大中药名店之一的叶开泰药店,距今已有近四个世纪的历史,现拥有十余个子公司,集生产、科研、经贸于一体,年生产能力近十亿元。

改革开放以来,集团公司以振兴民族医药为己任,积极推进企业改革,不断探索新的管理体制和运行机制,大力提高企业创新能力,促进了公司的全面发展,企业获得了比以往任何时候都好的社会效益和经济效益,创造了国有企业稳健经营的奇迹,综合实力跻身于全国企业500强和行业50强。近几年,集团大力实施科技兴业战略,确立了坚持以中药研发、生产和销售为主业,重点开发市场急需的小儿用药,老年用药和重大疑难病症用药,构建以中药现代化、产业化为基础,以高新技术药品为支撑的科技先导型医药集团。

目前,健民集团已成功地研制和开发出以龙牡壮骨颗粒、健民咽喉片、健脾生血颗粒、便通胶囊、慢肝宁胶囊为代表的系列产品,形成了集团蔚为壮观的"名牌林",产品行销全国,远销东南亚及欧美国家和地区。集团在近些年中相继荣获"全国质量效益型先进企业"、"全国中药行业优秀企业"、"全国五一劳动奖状"等称号,被誉为"搞好搞活国有企业的一面旗帜","健民"商标亦荣获"中国驰名商标"称号。一个以中药产业为基础,以高新科技为特征的健民集团必将在新的世纪里创更辉煌的业绩,谱写出振兴国药的优美乐章。

Longmu Zhuanggu Granule is a well-known brand under Wuhan Jianmin group, which has a glorious history of nearly 20 years and has created a long-lasting miracle in the field of Chinese medicine. It has nurtured the healthy growth of two generations of children in China. The main medicinal materials of Longmu Zhuanggu granules (such as Poria cocos, Ophiopogon japonicus, etc.) are directly selected from the gap medicinal materials planting base specially built by Wuhan Jianmin group, which are natural and authentic. There are strict quality control standards for each link and process in the production process, so that "unqualified raw materials are not allowed to enter the factory, unqualified semi-finished products are not transferred to the next process, and unqualified products are not allowed to leave the factory". Longmu Zhuanggu granules have been produced for 18 years and have been popular for 18 years, with a total output of 6 billion bags. The appearance and best-selling of "Longmu" has created amazing market performance and brand value, and also made Wuhan Jianmin, an enterprise with a long history but still young, full of vitality. Since then, it has been famous inside and outside the Great Wall, North and south of the river. "Longmu" once led the market of children's calcium supplement products. But now, it is faced with strong competition and challenge from other competitors, and the market share is constantly eroded and divided. He nurtured two generations of Chinese people. Born in Wuhan children's Hospital in 1985, it has filled in the blank of prevention and treatment of rickets in China with traditional Chinese medicine as the main body; in 1990, it was included in the drug standard of Hubei Province; in 1992, it was listed as the only one level of protection of traditional Chinese medicine for calcium supplement; in 1993, it was recommended as the best drug for children's calcium supplement and calcium absorption by China children's protection center; in 1994, it was recommended by the National Coordination Group for prevention and treatment of rickets It was listed as the first Chinese patent medicine; in 1995, it was listed in the drug standard of the Ministry of health; in 1999, it was listed as the national basic drug; in 2000, it was listed in the 2000 edition of the Chinese Pharmacopoeia; in 2002, it was listed as the national prescription medicine and over-the-counter medicine (OTC) double cross varieties; in the same year, it was listed in the pediatrics of traditional Chinese medicine (the textbook for the planning of the national higher education of traditional Chinese medicine in the new era). Wuhan Jianmin is one of the top 50 enterprises in China's pharmaceutical industry. The Group Co., Ltd. is a national key high-tech enterprise, a national production base of Chinese patent medicine for children and a national key Chinese medicine enterprise. The group's predecessor is Ye Kaitai drugstore, one of the four oldest famous traditional Chinese medicine stores in China. It has a history of nearly four centuries. Now it has more than ten subsidiaries, integrating production, scientific research and economic and trade, with an annual production capacity of nearly one billion yuan. Since the reform and opening up, the group company has taken the revitalization of national medicine as its own duty, actively promoted the enterprise reform, constantly explored new management system and operation mechanism, vigorously improved the innovation ability of the enterprise, promoted the overall development of the company, obtained better social and economic benefits than ever before, created a miracle of steady operation of state-owned enterprises, and its comprehensive strength ranks among Top 500 enterprises and top 50 industries in China. In recent years, the group has vigorously implemented the strategy of developing industry through science and technology, established a science and technology leading pharmaceutical group based on the modernization and industrialization of traditional Chinese medicine, supported by high-tech drugs, which adheres to the R & D, production and sales of traditional Chinese medicine as the main business, focuses on the development of children's drugs, elderly drugs and drugs for major and difficult diseases urgently needed in the market. At present, Jianmin group has successfully developed and developed a series of products represented by Longmu Zhuanggu granules, Jianmin Yanhou tablets, Jianpi Shengxue granules, Bentong capsules and manganning capsules, forming a spectacular "famous brand forest" of the group, which is sold all over the country and exported to Southeast Asia, European and American countries and regions. In recent years, the group has been awarded the titles of "national advanced quality and benefit enterprise", "national excellent enterprise in traditional Chinese medicine industry", "National May 1st Labor Award", etc., and is honored as "a banner for invigorating state-owned enterprises", and the "invigorating the people" trademark has also won the title of "China famous trademark". A Jianmin group based on traditional Chinese medicine industry and characterized by high and new technology is bound to make more brilliant achievements in the new century and compose a beautiful movement to revitalize traditional Chinese medicine.

本文链接: https://brand.waitui.com/f7f9487ec.html 联系电话:请联系客服添加 联系邮箱:请联系客服添加

外推网广告位招租,每天只要9块9

7×24h 快讯

阿里宋刚:突破用户体验瓶颈,将AI眼镜真正带入大众消费市场

36氪获悉,7月26日,2025世界人工智能大会(WAIC)开幕首日,阿里巴巴发布了首款自研AI眼镜——夸克AI眼镜的技术研发进展。负责该项目的阿里智能信息事业群终端业务负责人宋刚表示,阿里巴巴凭借AI能力与生态协同,突破用户体验瓶颈,将推动AI眼镜真正带入大众消费市场。宋刚提出,AI眼镜会是智能穿戴方向最重要的产品形态,它将成为人类另一双“眼睛”和“耳朵”,具备极强的场景穿透能力。宋刚透露:“未来我们还将持续探索AI眼镜在教育、健康、办公等更多场景的深度应用。”

19分钟前

得物人工智能查验系统获世界人工智能大会最高奖项“SAIL奖”

36氪获悉,7月26日,2025年世界人工智能大会(WAIC)开幕,得物人工智能查验系统亮相“中国人工智能产业创新成果展”,并斩获大会最高荣誉 "SAIL 奖"(Superior Achievement in AI Leadership,卓越人工智能引领者奖)。这是继入选中国信息通信研究院“大模型典型示范应用案例”和工信部“新型数字服务优秀案例”后,得物人工智能查验系统再度获得的重量级行业认证。

19分钟前

金可儿发布“悦智”智能床新品

7月26日,床垫品牌金可儿在上海世茂佘山洲际酒店发布“悦智”智能床产品,并通过多地联动,完成由中国著名女子跨栏运动员吴艳妮发起,300位参与者一起挑战的吉尼斯纪录。据介绍,“悦智”智能床以“全时护脊”为特点,通过搭载由爱梦集团与国家级专家联合研发的AI Dream智能引擎等多项创新研究,配合具有护脊性能设计的床垫,以及基于生活场景定制的四大模式等,为用户提供健康舒适的护脊体验。

19分钟前

小米:四年与徕卡合作超20款机型 销量数千万

36氪获悉,小米徕卡影像大赛特展今天开幕,四届影像大赛的100幅优秀作品参展。小米集团副总裁、首席营销官许斐介绍,小米徕卡影像大赛共收获数百万张参赛作品,真正做到了让影像走向大众。四年来,小米与徕卡推出20余款合作机型,销售数千万台。

19分钟前

有道“子曰”教育大模型最新应用成果亮相WAIC 2025

36氪获悉,7月26日,网易有道携国内首款AI原生学习硬件有道AI答疑笔SpaceOne亮相WAIC 2025,呈现出全新的AI答疑辅导新体验。活动现场,网易有道不仅带来了有道SpaceOne等智能学习硬件,更系统展示了网易有道词典、有道小P、有道精品课、有道领世、有道趣动屏、QAnything等“子曰”教育大模型在C端、B端的多款应用成果,形成了“技术-产品-场景”的完整生态闭环。

19分钟前

本页详细列出关于健民龙牡的品牌信息,含品牌所属公司介绍,健民龙牡所处行业的品牌地位及优势。
咨询